By Kevin E. Noonan — The U.S. Patent and Trademark Office Patent Trial and Appeal Board has declared interferences individually between Toolgen as Senior Party and as Junior Party the parties in the pending interference, Broad Institute, Harvard University, and the Massachusetts Institute of Technology (collectively, “Broad”) and The University of California/Berkeley, the University of Vienna, and Emmanuelle Charpentier (collectively, “CVC”) (see “Separate Interferences Declared between Toolgen and Broad and CVC over CRISPR Priority Question)”. This raises questions about the strength and priority position of Toolgen’s claims, which suggests a review of the prosecution might reap benefits in relevant comprehension….
